KNSA
KNSA
GB00BRXB0C07
Kiniksa Pharmaceuticals Interna
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
6.14B EUR
4.99B EUR
3.69B EUR
Enterprise Value
5.63B EUR
4.82B EUR
3.51B EUR
Valuation Multiples
Trailing P/E
80.59x
61.83x
50.54x
Forward P/E
49.32x
--
--
Price to Sales
7.3x
5.93x
4.9x
Price to Book
9.51x
7.62x
6.1x
EV/Revenue
6.69x
5.73x
4.66x
EV/EBITDA
55.15x
47.24x
37.01x
Price to FCF (P/FCF)
48.66x
27.27x
22.48x
EV/FCF
44.61x
26.36x
21.38x
FCF Yield
2.06%
3.67%
4.45%
ende